Abstract:While initially protective, prolonged neuroinflammation can lead to a disrupted brain microenvironment and neurodegenerative diseases. Microglia cells are the primary regulators of neuroinflammation, with anti- or pro-inflammatory phenotypes. Just as microglia are crucial in neuroinflammation, calcium is a crucial regulator in the activation of the microglia. Intracellular calcium dynamics can be modulated by small, membrane bound chaperone proteins called sigma receptors. Both sigma receptors 1 and 2, which are involved in a wide variety of cellular functions, have been implicated in neurodegenerative diseases, psychiatry, and cancer. We examined the use of sigma-receptor ligands to modulate cytosolic calcium levels in BV2 cells, an immortalized mouse microglia cell line. Immunofluorescence staining detected both sigma 1 and 2 receptors in perinuclear regions and the cell cytoplasm. Our selection of compounds was a mixture of commercially available sigma receptor ligands and compounds synthesized at Southern Illinois University Edwardsville. We used the Fluo-8-AM calcium probe to measure cytosolic calcium concentrations using flow cytometry after 15-, 25- and 35-minute ligand exposure. With 1 μM ligand concentration, we found significantly increased cytosolic calcium levels in BV2 cells after 15-minute exposure. A moderate correlation was determined between sigma receptor 2 selectivity and calcium activity, suggesting a sigma-mediated calcium effect. In addition, we aimed to determine the location of calcium flux by pretreating cells with thapsigargin and EGTA to inhibit both the endoplasmic reticulum and extracellular space of suspected calcium entry. We found all four compounds tested, siramesine, PB-28, cis-8-OMe BBZI, and BN-IX-111-F1 promote calcium entry from the extracellular space, but only siramesine promotes calcium entry from both locations. We tested for a common drug-induced effect called phospholipidosis using HCS LipidTOX phospholipid detection reagent to determine a correlation between calcium activity and a membrane-mediated effect. Only two out of the five compounds tested, PB-28 and amiodarone, resulted in significant phospholipid accumulation at 10 μM treatment, suggesting little to no correlation between calcium levels and phospholipidosis. Further investigations are required to target the exact mechanism of calcium flux and characterize the connection between phospholipidosis and sigma receptors after sigma ligand exposure. Nevertheless, our work emphasizes the importance of sigma ligand-modulated intracellular calcium dynamics as a potential route of therapy, specifically for modulation of neuroinflammation.

Proinflammatory Effects of S100a8/A9 Via Tlr4 and Rage Signaling Pathways in Bv-2 Microglial Cells

Direct anti‐inflammatory effects of angiotensin‐(1–7) on microglia

Proinflammatory S100A9 stimulates TLR4/NF-κB signaling pathways causing enhanced phagocytic capacity of microglial cells

S100A4 promotes experimental autoimmune encephalomyelitis by impacting microglial inflammation through TLR4/NF-κB signaling pathway

S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells

S100A8 Promotes Inflammation via Toll-Like Receptor 4 After Experimental Traumatic Brain Injury

IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase.

Lps-Induced Prongf Synthesis and Release in the N9 and Bv2 Microglial Cells: A New Pathway Underling Microglial Toxicity in Neuroinflammation

Expression of TNF- and IL- can be suppressed via the PPAR-/mTOR signaling pathway in BV-2 microglia: A potential anti-inflammation mechanism

NMDA receptor inhibitor MK801 alleviated pro-inflammatory polarization of BV-2 microglia cells

Amyloid Precursor-Like Protein 2 C-terminal Fragments Upregulate S100A9 Gene and Protein Expression in BV2 Cells

S100A8/9 modulates perturbation and glycolysis of macrophages in allergic asthma mice

Tumor necrosis factor α-induced protein 8-like-2 controls microglia phenotype via metabolic reprogramming in BV2 microglial cells and responses to neuropathic pain

Alarmins S100A8/A9 Promote Intervertebral Disc Degeneration and Inflammation-Related Pain in a Rat Model Through Toll-Like Receptor-4 and Activation of the NF-κB Signaling Pathway.

Characterization of Inflammatory Signals in BV-2 Microglia in Response to Wnt3a

C16 Peptide and Angiopoietin-1 Protect Against LPS-induced BV-2 Microglial Cell Inflammation.

Inflammatory role of S100A8/A9 in the central nervous system non-neoplastic diseases

Study on the involvement of microglial S100A8 in neuroinflammation and microglia activation during migraine attacks

Expression of TNF‐α and IL‐β can be suppressed via the PPAR‐γ/mTOR signaling pathway in BV‐2 microglia: A potential anti‐inflammation mechanism

S100A9 Increases IL-6 and RANKL Expressions through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells

Sigma Ligand-mediated Cytosolic Calcium Modulation in BV2 Microglia Cells